相关实验视频

Updated: Jun 1, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

使用美国和澳大利亚队列的临床变量开发多因素痴呆症预测模型

Caitlin A Finney^1,2, David A Brown^3,4,5, Artur Shvetcov^6,7,8

¹Translational Dementia Research Group, Centre for Immunology and Allergy Research, Westmead Institute for Medical Research, Sydney, NSW, 2145, Australia. caitlin.finney@wimr.org.au.

Translational psychiatry

|January 21, 2025

概括

APOE基因型显示出预测痴呆症的前景,其表现优于其他临床措施. 然而,数据的局限性突显出需要进一步研究基因测试和统一的队列数据,以改善痴呆症诊断.

科学领域:

神经科学是一个神经科学.
遗传学遗传学是一个
机器学习机器学习

背景情况:

目前使用非神经成像临床数据的痴呆症预测模型显示诊断准确性有限.
在临床实践中,确定可靠的痴呆早期生物标志物仍然是临床实践中的重大挑战.

研究的目的:

用机器学习重新评估痴呆症临床措施的诊断潜力.
评估各种临床变量的预测能力,包括APOE基因型,用于痴呆症分类.

主要方法:

利用机器学习算法,包括基于树的方法和人工神经网络.
分析了来自两个主要队伍的临床数据:澳大利亚成像,生物标志物和生活方式 (AIBL) 研究和阿尔茨海默病神经成像计划 (ADNI).
包括21个临床变量:病史,血液测试和APOE基因型.

主要成果:

APOE基因型成为区分痴呆病例与健康对照病例的最强预测因素.
机器学习模型展示了临床措施在痴呆症预测中的潜力.
鉴定了由于使用公开可访问的队列数据而导致的概括性和解释性的局限性.

结论:

APOE基因测试需要进一步调查以进行常规的痴呆症诊断.
未来的研究应该专注于统一跨不同临床队列的数据,以提高模型的稳定性.
提高数据可访问性和标准化对于开发更具普遍性的痴呆症预测模型至关重要.

更多相关视频

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

Basics of Multivariate Analysis in Neuroimaging Data

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

相关概念视频

Dementia

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...